Advertisement
Do you suffer from chronic pain?
Learn how straightening up can ease your pain
Chronic pain management tips
Learn how straightening up can ease your pain
Chronic pain management tips
More DailyStrength



(also known as Efalizumab)
Efalizumab (Raptiva, Genentech) is a medication used to treat psoriasis. It is a recombinant humanized monoclonal antibody that binds to CD11a and acts as an immunosuppressant. It is administered once weekly by subcutaneous injection.
more at Wikipedia

Treatment Success Rate
| Top 5 Communities | ||
| Condition | Members | Success |
| Psoriasis | 36 |
72% |
| Bipolar Disorder | 14 |
79% |
| Depression | 3 |
100% |
| Personality Disorders | 3 |
100% |
| Bipolar Disorder - Teen | 3 |
100% |
Overall, 77% (74
Members)
find Raptiva helpful

Advertisement

Raptiva Reviews
Working / Worked
Didnt work
Working / Worked
I do not know this drug .
Working / Worked
Worked very good but has been discontinued
Working / Worked
Since Im also bipolar Geodon has had a major affect on my eating disorder.
Working / Worked
It worked, then it shut down my immune system, landed me in the hospital and almost made me go septic.
Working / Worked
medication that also helps with my bipolar tendencies that includes mainly impulsivity for me.
Working / Worked
this was an excellent drug for me. I was in the case study for two years before this drug was commercially available. Once it became available I used it for an additional 3+ years until it was removed from the market. I recieved excellent results from this drug. I was taken off this drug in September 2009 and was put on Humeria.
Working / Worked
worked great for 5 years then had massive reaction and flared up to 90% of my skin covered. Took 2 years to recover
Working / Worked
a chemical lobotomy!
Working / Worked
worked pretty well
Showing 1 - 10 of 72 Reviews


Discussions
-
Ingredient in New MS Drug Linked to Brain Disease
This doesn't mean that the BG12 is definitely harmful - but it's worth taking a look at this..... By Brenda Goodman, HealthDay News WEDNESDAY, A... [More]







